Accessibility Menu
 
Embecta logo

Embecta

(NASDAQ) EMBC

Current Price$8.86
Market Cap$524.10M
Since IPO (2022)-78%
5 YearN/A
1 Year-26%
1 Month-9%

Embecta Financials at a Glance

Market Cap

$524.10M

Revenue (TTM)

$1.08B

Net Income (TTM)

$139.50M

EPS (TTM)

$2.37

P/E Ratio

3.73

Dividend

$0.60

Beta (Volatility)

0.00 (Low)

Price

$8.86

Volume

29,646

Open

$8.70

Previous Close

$8.86

Daily Range

$8.54 - $8.96

52-Week Range

$8.47 - $15.55

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Embecta

Industry

Healthcare Equipment and Supplies

Employees

1,850

CEO

Devdatt Kurdikar, PhD, MBA

Headquarters

Parsippany, NJ 07054, US

EMBC Financials

Key Financial Metrics (TTM)

Gross Margin

64%

Operating Margin

32%

Net Income Margin

13%

Return on Equity

0%

Return on Capital

42%

Return on Assets

13%

Earnings Yield

26.81%

Dividend Yield

0.07%

Payout Ratio

25.16%

Stock Overview

Market Cap

$524.10M

Shares Outstanding

59.22M

Volume

29.65K

Short Interest

0.00%

Avg. Volume

842.84K

Financials (TTM)

Gross Profit

$679.50M

Operating Income

$329.30M

EBITDA

$294.70M

Operating Cash Flow

$191.70M

Capital Expenditure

$9.30M

Free Cash Flow

$182.40M

Cash & ST Invst.

$225.50M

Total Debt

$1.43B

Embecta Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$261.20M

-0.3%

Gross Profit

$175.60M

+5.2%

Gross Margin

67.23%

N/A

Market Cap

$524.10M

N/A

Market Cap/Employee

$262.05K

N/A

Employees

2,000

N/A

Net Income

$44.10M

+6400.0%

EBITDA

$95.90M

+145.3%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$1.22B

+11.1%

Accounts Receivable

$159.20M

-27.8%

Inventory

$181.80M

+7.5%

Long Term Debt

$1.40B

-10.5%

Short Term Debt

$13.00M

+0.8%

Return on Assets

13.11%

N/A

Return on Invested Capital

41.75%

N/A

Free Cash Flow

$16.60M

+344.1%

Operating Cash Flow

$17.20M

+424.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PSNLPersonalis, Inc.
$6.58+0.30%
PRMEPrime Medicine, Inc.
$3.32-2.06%
MYGNMyriad Genetics, Inc.
$4.75+3.49%
EBSEmergent BioSolutions Inc.
$8.23-1.79%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
INTCIntel
$50.38+0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%

Questions About EMBC

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.